SOX2 and neoplasm: Elevation of SOX2 expression in tumor-propagating cells could be attributed to the fact that SOX2 promoter becomes immensely operative under stress conditions upon exposure to different anti-tumor therapies, thus, enabling them to survive under therapy-driven adverse environments and ultimately the process leads to disease relapse through generation of CSCs.